Genesis Financial Group LLC Invests $996,000 in SPDR S&P Biotech ETF $XBI

Genesis Financial Group LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 7,800 shares of the exchange traded fund’s stock, valued at approximately $996,000.

A number of other institutional investors and hedge funds have also bought and sold shares of XBI. Financial Life Planners bought a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $27,000. Intesa Sanpaolo Wealth Management purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $30,000. SHP Wealth Management bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at $32,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $147.91 on Thursday. The firm has a market cap of $9.73 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The business has a 50-day simple moving average of $145.48 and a two-hundred day simple moving average of $134.07. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.